跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 98,890 条关于
“Graves' Eye Disease”
全部
98,890
临床试验
74,759
药物
1,711
机构
334
资讯
22,086
去年
Novel Chimeric Autoantibody Receptor T Cells Show Promise for Treating Graves' Disease
去年
EMA Recommends Approval of Tepezza for Thyroid Eye Disease, First Targeted Treatment in EU
3个月前
Ethyreal Bio Launches With $101 Million to Advance Dual-Targeting TSHR Antibody for Graves' Disease and Thyroid Eye Disease
9个月前
GenSci Partners with RTW Investments in $1.365 Billion Deal for First-in-Class Thyroid Autoimmune Disease Therapy
3个月前
Regeneron Unveils Pivotal Phase 3 Garetosmab Data in FOP as FDA Priority Review Underway, Alongside Metabolic and Ophthalmology Pipeline Advances
18天前
Eli Lilly to Acquire Merida Biosciences for Up to $2.88 Billion, Adding Novel Autoantibody-Targeting Pipeline
去年
Crinetics Pharmaceuticals Submits NDA for Paltusotine in Acromegaly Treatment
上个月
VYNE Therapeutics and Yarrow Bioscience Merger Nears Completion: Cash Dividend Distributed, Reverse Stock Split Set, and YB-101 Poised to Advance Autoimmune Thyroid Disease Pipeline
2年前
Immunovant's IMVT-1402 Shows Promise in Graves' Disease Treatment
2年前
Immunovant's Batoclimab Shows Promise in Graves' Disease Phase II Trial; IMVT-1402 Pivotal Trial Planned
第 1 页,共 2209 页
上一页
下一页